Considering the essential role of AMPK as a metabolic regulator in obesity, our results suggest that RYGB stimulates adaptive responses in leukocytes that may facilitate the partial recovery of cellular homeostasis, with potential systemic effects on inflammation and IR. Here, PRKAA1 is linked to obesity due to melanocortin 4 receptor deficiency.